OMNIPAQUE 12 mg/mL (Iohexol SOLUTION) 12 mg/mL

OMNIPAQUE 12 mg/mL is a radiocontrast agent used for diagnostic imaging procedures. This solution enhances visibility during X-rays and CT scans, aiding in accurate medical assessments. Ideal for healthcare professionals seeking reliable contrast media.

Strength

12 mg/mL

Pack Size

10 BOTTLE, PLASTIC in 1 BOX (0407-1416-12) / 500 mL in 1 BOTTLE, PLASTIC

Manufacturer / TM Owner

GE Healthcare Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OMNIPAQUE 12 mg/mL is primarily used as a contrast medium in diagnostic imaging. It helps improve the clarity of X-rays and CT scans by enhancing the visibility of internal structures. This solution is often utilized in procedures requiring detailed imaging of the body's interior, making it easier for healthcare providers to identify and assess various conditions.

Side Effects

When administered, OMNIPAQUE 12 mg/mL may cause a temporary warming sensation or a mild metallic taste. Some individuals might experience a brief feeling of warmth or flushing. These effects are generally short-lived and subside quickly after the procedure.

Precautions & Warnings

OMNIPAQUE 12 mg/mL should be handled with care and used under the supervision of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before use. Proper storage and handling are essential to maintain the integrity of the solution.

Avoid Interactions

OMNIPAQUE 12 mg/mL may interact with certain medications or substances. It is advisable to discuss any current medications with a healthcare provider before undergoing procedures involving this contrast agent. Alcohol and other substances should be avoided unless approved by a medical professional.

Frequently Asked Questions

OMNIPAQUE 12 mg/mL is used as a contrast medium to enhance the visibility of internal structures during X-rays and CT scans.

OMNIPAQUE 12 mg/mL is typically administered orally under the supervision of a healthcare professional.

Common effects may include a temporary warming sensation or a mild metallic taste, which usually subside quickly.

Yes, it is important to inform your healthcare provider about any allergies or medical conditions before use.

Potential interactions may occur, so it is advisable to discuss current medications with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.